Vontobel Holding
NVAX icon

Vontobel Holding’s Novavax NVAX Stock Holding History

Vontobel Holding’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Sell
59,865
-4,271
-7% -$38.3K ﹤0.01% 1009
2026
Q1 		$522K Sell
64,136
-35,817
-36% -$325K ﹤0.01% 834
2025
Q4 		$672K Buy
99,953
+37,720
+61% +$284K ﹤0.01% 893
2025
Q3 		$540K Sell
62,233
-14,488
-19% -$113K ﹤0.01% 923
2025
Q2 		$483K Buy
76,721
+901
+1% +$5.97K ﹤0.01% 908
2025
Q1 		$486K Sell
75,820
-354,917
-82% -$2.93M ﹤0.01% 790
2024
Q4 		$3.46M Sell
430,737
-67,795
-14% -$654K 0.01% 371
2024
Q3 		$6.3M Buy
498,532
+261,464
+110% +$3.38M 0.02% 285
2024
Q2 		$3M Sell
237,068
-21,663
-8% -$218K 0.01% 373
2024
Q1 		$1.24M Buy
258,731
+50,410
+24% +$234K 0.01% 528
2023
Q4 		$1,000K Sell
208,321
-5,644
-3% -$34.5K 0.01% 591
2023
Q3 		$1.55M Buy
213,965
+127,498
+147% +$1.02M 0.01% 482
2023
Q2 		$642K Sell
86,467
-82,958
-49% -$652K 0.01% 727
2023
Q1 		$1.17M Buy
169,425
+76,525
+82% +$704K 0.01% 544
2022
Q4 		$955K Sell
92,900
-1,165
-1% -$20.6K 0.01% 590
2022
Q3 		$1.71M Buy
94,065
+39,839
+73% +$1.73M 0.02% 432
2022
Q2 		$2.81M Buy
54,226
+14,955
+38% +$775K 0.03% 338
2022
Q1 		$2.94M Buy
39,271
+15,154
+63% +$1.35M 0.03% 361
2021
Q4 		$3.73M Buy
24,117
+5,048
+26% +$867K 0.03% 310
2021
Q3 		$3.95M Buy
19,069
+4,703
+33% +$1.04M 0.03% 309
2021
Q2 		$3M Sell
14,366
-9,954
-41% -$1.82M 0.03% 357
2021
Q1 		$4.41M Buy
24,320
+7,208
+42% +$1.44M 0.03% 278
2020
Q4 		$5.47M Buy
+17,112
New +$1.82M 0.04% 254

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Vontobel Holding's NVAX Position: Q2 2026 in Review

Vontobel Holding reduced its Novavax (NVAX) stake by 6.7% in Q2 2026, selling an estimated $38.3K and leaving 59,865 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Vontobel Holding first reported a position in NVAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.3M in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Vontobel Holding held 59,865 shares of Novavax worth $564K as of Q2 2026.
  • Vontobel Holding sold 4,271 Novavax shares in Q2 2026, an estimated $38.3K.
  • Novavax made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1009 holding.
  • Vontobel Holding first reported a position in Novavax in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Novavax position peaked at $6.3M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.